Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases. Its pipeline includes NPM-139 for chronic weight management in patients who are obese or overweight; NPM-133 a semaglutide implant for the treatment of patients with type 2 diabetes; NPM-115, an exenatide implant candidate for chronic weight management in patients who are obese or overweight; and OKV-119, an exenatide implant for the treatment of obesity and diabetes in companion animals, including cats and dogs. The company is headquartered in Alameda, California.
Frequently asked questions
What sector does Vivani Medical Inc. (VANI) operate in?
Vivani Medical Inc. belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Vivani Medical Inc. (VANI) current stock price?
As of the latest data, Vivani Medical Inc. stock price is $1.45, with a previous close of $1.35. Vivani Medical Inc. gained $0.10 in the last trading session, representing a 7.41% increase.
What is Vivani Medical Inc. (VANI) current market capitalization?
Vivani Medical Inc. market cap is approximately 130.79 million.
What is Vivani Medical Inc. (VANI) Earnings Per Share (EPS)?
The trailing EPS is -$0.36, and the forward EPS is -$0.40.
What is Vivani Medical Inc. (VANI) EBITDA?
Vivani Medical Inc. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -7.38 million.
Does Vivani Medical Inc. (VANI) pay dividends?
No. Vivani Medical Inc. does not pay a dividend.
What is Vivani Medical Inc. (VANI) beta (volatility) score?
Vivani Medical Inc. has a beta of 3.282, indicating very high volatility compared to the market.
